Accumulation of Intrahepatic Islet Amyloid in a Nonhuman Primate Transplant Model
Open Access
- 21 February 2012
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 153 (4) , 1673-1683
Abstract
Islet amyloid is hypothesized to play a role in nonimmunologic transplanted islet graft loss. We performed a quantitative histologic analysis of liver biopsies from intrahepatic islet grafts transplanted in streptozotocin-induced diabetic cynomolgus macaques. Seven animals treated with antithymocyte globulin (ATG) and rapamycin or ATG and rituximab experienced islet graft rejection with lymphocytic infiltrates present on islet graft biopsies. Except for one case involving the oldest and largest donor where amyloid was present on initial biopsy 1 month after transplant, none of the six other cases with rejection contained amyloid, including one case biopsied serially to 25 months. In contrast, four out of six animals treated with ATG and rituximab and rapamycin had no evidence of rejection at the time of biopsy (two animals that discontinued rapamycin had mild periislet lymphocytes), and all four cases followed more than 4 months demonstrated amyloid deposition at subsequent time points. Amyloid severity increased with time after transplant (r = 0.68; P < 0.05) and with decreasing islet β-cell area (r = −0.68; P < 0.05). In two islet recipients with no evidence of rejection and still normoglycemic and insulin independent at the first detection of amyloid, β-cell secretory capacity declined over time coincident with increasing amyloid severity and decreasing β-cell area, with both animals eventually becoming hyperglycemic and insulin dependent. Transplanted islet amyloid also developed in autologous islets placed sc. These results indicate that in cynomolgus macaques, transplanted islets may accumulate amyloid over time associated with subsequent decline in β-cell mass and function and support the development of intrahepatic islet amyloid as a potential mechanism for nonimmunologic islet graft loss.Keywords
This publication has 46 references indexed in Scilit:
- β-Cell Loss and β-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid DepositionThe American Journal of Pathology, 2011
- Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse isletsDiabetologia, 2011
- Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide DegradationJournal of Biological Chemistry, 2010
- Islet amyloid deposition limits the viability of human islet grafts but not porcine islet graftsProceedings of the National Academy of Sciences, 2010
- 2008 Update From the Collaborative Islet Transplant RegistryTransplantation, 2008
- Small Interfering RNA–Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in CultureDiabetes, 2008
- Islets in Type 2 Diabetes: In Honor of Dr. Robert C. TurnerDiabetes, 2008
- Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graftProceedings of the National Academy of Sciences, 2006
- Effects of beta cell granule components on human islet amyloid polypeptide fibril formationFEBS Letters, 1996
- PURIFIED CANINE ISLET AUTOGRAFTSTransplantation, 1990